IBILZEO
DEAD

Serial Number

79295701

Owner

NOVARTIS AG

Filing Date

Jul 13, 2020

Add to watchlist:

No watchlists yet
View on USPTO

IBILZEO Trademark

Serial Number: 79295701

IBILZEO is a trademark filed by NOVARTIS AG on July 13, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,173 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

July 13, 2020

Registration Date

Not Registered

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Nov 4, 2021 DENA
DEATH OF INTERNATIONAL REGISTRATION
Nov 3, 2021 DETH
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jun 4, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 4, 2021 ABN2
REFUSAL PROCESSED BY IB
Dec 7, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 16, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 16, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 31, 2020 RFCR
NON-FINAL ACTION WRITTEN
Oct 30, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 24, 2020 MAFR
ASSIGNED TO EXAMINER
Oct 23, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 20, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 19, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 15, 2020 REPR